The PRMT5 Inhibitor C9 Mitigates Hypoxia-Induced Carboplatin Resistance in Lung Cancer by Inducing Autophagy

Hypoxia upregulated PRMT5 expression in lung cancer cells. Additionally, PRMT5 overexpression promoted cancer cell resistance to carboplatin.